Zota Health Care Limited has announced a final dividend of 10%, equivalent to Re. 1 per equity share of ₹10 each, for the financial year 2025-26. This decision was taken during the company’s Board of Directors meeting held on 22 May 2026 in Surat, Gujarat. The proposed dividend is subject to approval by shareholders at the forthcoming Annual General Meeting.
In addition to the dividend declaration, the board approved the standalone and consolidated audited financial results for the quarter and year ended 31 March 2026. The audit reports, issued by M/s. Pradeep K. Singhi & Associates, Chartered Accountants, were presented with an unmodified opinion. These financial results will be accessible on the National Stock Exchange of India’s website and the company’s official website.
Furthermore, the board sanctioned the acquisition of 39,794 equity shares of M/s Davaindia Health Mart Limited, a wholly-owned subsidiary, through subscription to a rights issue. This strategic move is part of the company’s ongoing efforts to strengthen its subsidiary holdings.
The board meeting commenced at 11:00 A.M. and concluded at 6:15 P.M. The decisions taken are part of Zota Health Care‘s strategic initiatives to enhance shareholder value and expand its operational footprint.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).